Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03781960
Title Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

hepatocellular carcinoma

Therapies

Abemaciclib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field